Network Insights Methodology Whitepaper Get Access

CVS Health

ORG Health Care / Integrated Health Care Delivery Momentum 6.4ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration.

$322B market cap (Woonsocket) operates integrated pharmacy, PBM, and health insurance services across 9,900+ retail locations. Facing 340B pricing litigation while capitalizing on GLP-1 drug demand surge.

Defending against 340B drug pricing program lawsuits while expanding GLP-1 weight-loss medication distribution and pharmacy services.
0.00
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
6.4
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
0%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
9
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
UnitedHealth Group PlocamiumAI Americans CMS NYSE NEW YORK FDA Eli Lilly Novo Nordisk
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-28 2026-06-20 9 0 Degree Mentions
Signal Decomposition
No signal data available.
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
9 Degree Centrality
Ego Network (top connections)
UnitedHealth Group (weight 6.0)PlocamiumAI (weight 4.0)Americans (weight 4.0)CMS (weight 2.0)NYSE (weight 2.0)NEW YORK (weight 2.0)FDA (weight 2.0)Eli Lilly (weight 1.0) UnitedHealth GroupPlocamiumAIAmericansCMSNYSENEW YORKFDAEli Lilly CVS Health (degree 9) CVS Health
Centrality History
2026-05-28 2026-06-20 9 0 Degree Mentions
EntityWeight StatusFirst Seen
UnitedHealth Group 6 NEW
PlocamiumAI 4 NEW
Americans 4 NEW
CMS 2 NEW
NYSE 2 NEW
NEW YORK 2 NEW
FDA 2 NEW
Eli Lilly 1 NEW
Novo Nordisk 1 NEW
Article Coverage (11)
DateLaneTitle
2026-05-27 Healthcare M&A Cencora Poaches CVS Finance Leader to Navigate Prescription Drug Pressures
2026-05-23 Healthcare Marketing Tennessee Strips Pharmacy Benefit Managers of Store Ownership Rights Amid Growing Pushback
2026-05-23 Healthcare Marketing Tennessee Strips Pharmacy Benefit Managers of Store Ownership Rights Amid Growing Pushback
2026-05-23 Healthcare M&A Private Equity Floods Pain Management as Opioid Era Ends, Creating Defensive Plays
2026-05-15 Healthcare M&A CVS Exits Low-Margin Pharmacy Business as Healthcare Integration Strategy Crumbles
2026-05-15 Healthcare M&A CVS Exits Low-Margin Pharmacy Business as Healthcare Integration Strategy Crumbles
2026-05-14 Healthcare Marketing UnitedHealth, CVS, Elevance Abandon Insurance to Become AI Software Vendors
2026-05-14 Healthcare Marketing UnitedHealth, CVS, Elevance Abandon Insurance to Become AI Software Vendors
2026-05-14 Healthcare Marketing UnitedHealth, CVS, Elevance Abandon Insurance to Become AI Software Vendors
2026-05-07 Healthcare Marketing Aetna's Insurance Gains Push CVS to Lift Annual Outlook
2026-03-24 Healthcare M&A Novartis to Invest $480M in China Following AstraZeneca and Lilly Pledges

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-20 ← Intelligence Network